To examine the recent literature on the role of innate cells in immunity to transplanted tissue. It specifically addresses the impact of monocytes/macrophages, neutrophils, natural killer cells, and platelets.
INTRODUCTION
In 2012, more than 28 000 transplants were performed in the USA from living and deceased donors [1] . Five-year survival rates range from 38% (for intestinal and heart/lung transplants) to over 70% (for kidney and kidney and pancreas transplants). Much research has been dedicated to examining adaptive immune responses in transplant rejection. However, the innate immune system cannot be ignored and may hold within it targets to prolong graft survival. The innate immune system is the first line of defense against pathogens and in response to sterile injury. It consists of several cell types including monocytes, macrophages, neutrophils, natural killer (NK) cells, platelets, NKT cells, and gd cells. Innate cells recognize broadly expressed molecules derived from pathogens or apoptotic cells. They not only have both pro-inflammatory and anti-inflammatory effects on their own, but also play an important role in priming adaptive immune responses. We will discuss the various ways in which monocytes, macrophages, neutrophils, NK cells and platelets influence organ transplantation.
MONOCYTES AND MACROPHAGES
Monocytes are circulating phagocytic cells that give rise to tissue-resident dendritic cells or macrophages. Macrophages can modulate the adaptive immune response with either pro-inflammatory or anti-inflammatory effects [2] .
Monocytes in graft function
In renal transplantation, graft survival has been shown to be associated with infiltration of monocytes. Increased presence of these cells or their macrophage counterparts within glomeruli, but not in peritubular capillaries or the interstitium, is associated with decreased graft survival. Oneyear graft survival was 55.8% when higher numbers of monocytes were present in the glomerulus, but survival was as high as 90% with lower numbers of these cells [3] . Similar findings have been shown for pediatric patients following intestinal transplantation. In an attempt to find markers that could predict intestinal transplant rejection, Ashokkumar [4] investigated sialoadhesin expression on infiltrating monocytes. This immunoglobulin-like lectin is a marker of activation for these cells and is induced in response to interferon (IFN)-a. More than 99% of monocytes in the blood of patients experiencing rejection expressed this molecule, whereas only 12% expressed the same molecule in nonrejecting patients. To this end, it has been suggested that detection of sialoadhesin prior to transplantation and early after engraftment could be used to predict rejection [4] .
In-vitro studies have suggested that recruitment of monocytes into grafted tissue is dependent on recipient antibodies binding to endothelialexpressed donor human leukocyte antigen (HLA) I molecules. This interaction caused increased expression of the adhesion molecule P-selectin. Recruitment of monocytes into the graft was further facilitated by monocyte FcgR binding to the HLAantibody complex leading to enhanced expression of P-selectin. These two interactions facilitated monocyte firm adhesion to intercellular adhesion molecule-1 [5] . These results were confirmed in vivo, where transplantation of allogeneic hearts with anti-HLA-1 antibodies increased macrophage infiltration into the graft at 30 days. This effect was diminished if a P-selectin antagonist was administered [6] .
Much effort has been put forth to determine the mechanisms by which monocytes contribute to graft rejection. Co-culture experiments using peripheral blood mononuclear cells and human aortic endothelial cells have shown an increase in the chemoattractant molecule chemokine (C-X-C) ligand-10 in response to tumor necrosis factor (TNF)-a stimulation. Expression of this molecule was minimal when either monocytes or endothelial cells were cultured alone, but increased dramatically when the two populations were cultured together [7] . These results provide a possible mechanism by which monocytes influence the recruitment of T cells and other inflammatory cells to grafted tissue leading to rejection.
Detrimental effects of macrophages following transplant
Infiltration of monocyte-derived macrophages is associated with acute cellular rejection (ACR) in pediatric intestinal transplants. At timepoints immediately following reperfusion, early after transplant and late after transplant, patients who later undergo ACR had much higher infiltration of macrophages compared with those who did not experience rejection. Importantly, these monocyte-derived macrophages also expressed high amounts of chemokine (C-C) ligand, a T-cell chemoattractant [8] . Intravascular macrophages also correlate with antibody-mediated rejection in heart transplant recipients within the first year of surgery [9] . These two studies indicate a mechanism by which innate and adaptive immune responses interface in the rejection of allografts.
Evidence has recently emerged that monocytes and macrophages have the ability to generate an immune response to allogeneic cells on their own, a function generally attributed only to cells of the adaptive immune system. Zecher [10] demonstrated that monocytes could mount immune responses to allogeneic splenocytes in recombination activation gene (RAG) -/mice, which lack T and B cells, and were able to elicit recall responses 4 weeks later. Adoptive transfer of monocytes from alloimmunized RAG -/was able to transfer immunity to naïve RAG -/mice. Alloimmunity was shown to be independent of major histocompatibility complex (MHC) molecules, major determinants of T-cellmediated transplant rejection. Further, proof of macrophages rejecting allogeneic cells was provided by Liu, who showed that macrophages require priming by encounter with antigen and interaction with CD4 þ T cells to kill allogeneic cells during a second encounter [11] . CD40-CD40L interactions between CD4 þ T cells and macrophages were required and the allogeneic cells were eliminated through phagocytosis. This study also showed that primed macrophages are a potential treatment for graft-versus-host disease (GVHD). Mice receiving allogeneic T cells with primed macrophages had improved survival compared with those only receiving allogeneic T cells, indicating that macrophages were able to eliminate cells responsible for causing GVHD.
In the above studies, Zecher showed an MHCindependent role of monocytes/macrophages in alloimmunity, whereas Liu demonstrated some specificity of macrophage alloimmunity based on which H-2 molecule was used in priming. Receptors have been found that are specific for H-2 molecules [12, 13] . These macrophage MHC receptors (MMRs) are important in the rejection of allogeneic skin
KEY POINTS
The role of innate cells in transplantation is underappreciated.
Monocytes/macrophages, neutrophils, and NK cells all have the ability to promote tolerance or facilitate rejection.
Innate immune cells are capable of influencing the adaptive immune system. grafts, but not lymphoma cells. Mice lacking MMR2 did not reject H-2K d skin grafts, but were able to reject grafts from mice expressing H-2I d . These results showed specificity of MMR2 for H-2K d . Indeed, a separate receptor, MMR1 is specific for H-2D d [14 & ]. Lung recipients have a median 5-year survival of only 57.5%, which is in large part because of the development of bronchiolitis obliterans characterized by fibrosis of the small airways [15] . In this process, transforming growth factor (TGF)b is critical in inducing fibroblast proliferation and causing epithelial-to-mesenchymal transition [16] . Borthwick investigated the role that macrophages could play in this process. Alveolar macrophages from the bronchoalveolar lavage fluid of lung recipients were induced to become either classically activated macrophages (CAM) or alternatively activated macrophages (AAMs) and then stimulated with Pseudomonas aeruginosa. CAM responded by producing more TNF-a and interleukin (IL)-8 than AAM. TNF-a, but not IL-8 or IL-1b, enhanced the profibrotic effects of TGF-b, suggesting that CAM may exacerbate bronchiolitis obliterans. A small proof-of-concept study involving treatment of patients exhibiting progressive bronchiolitis obliterans syndrome with a monoclonal antibody targeting TNF-a was encouraging. Lung function improved in four out of five patients after 4 weeks of treatment [17] .
Innate immune cells in transplantation

Beneficial role of macrophages in transplantation
Macrophages can play a protective role in allograft survival as they can be induced to have a regulatory (Mreg) phenotype in response to IFN-g. These Mregs can suppress the allostimulation of T cells through the production of inducible Nitric Oxide Synthase (iNOS), which decreases IL-2 and IFN-g production and inhibits proliferation. Mregs also eliminate allogeneic T cells directly through phagocytosis and ex-vivo-generated Mregs can significantly extend the survival of cardiac allografts [18] .
A separate subset of regulatory myeloid cells also functions through production of iNOS. These cells termed myeloid-derived suppressor cells (MDSCs) are distinct from the above-mentioned Mregs and are identified as CD11b þ Gr1 þ cells. Wu [19] showed that TGF-b was important in the regulation of MDSC suppressive effects. Surprisingly, the presence of TGF-b and the downstream signaling molecule Smad3 (normally associated with anti-inflammatory effects) decreased the production of iNOS and therefore counteracted the suppressive effects of MDSC on alloreactive T cells. Following skin transplantation, Smad3-deficient mice had a survival advantage compared with wildtype mice.
Kupffer cells, liver-resident macrophages, have been suggested to contribute to tolerance induction. In the rat, distinct combinations of donor-recipient strains result in either tolerance or rejection of liver allografts. Luan [20] has shown that Kupffer cells from tolerant combinations have increased expression of indoleamine 2,3-dioxygenase (IDO) compared with cells isolated from rejecting combinations. IDO is important in the degradation of tryptophan, leading to the depletion of a key molecule necessary for efficient T-cell proliferation [21] . Kupffer cell production of IDO may therefore regulate allogeneic T-cell responsiveness.
Macrophages are also important in wound healing and this holds true in the case of transplantation as well. Following corneal transplantation, clodronate depletion of macrophages reduces neovascularization and leads to irregular extracellular matrix alignment and detachment of donor corneas [22] . This study highlights the negative impact of eliminating all macrophages following transplantation and points to the need to target specific subsets or molecules involved in rejection.
NEUTROPHILS
Neutrophils are bone-marrow-derived cells that mediate early immune responses to infection. These cells also play a role in transplant-mediated ischemia-reperfusion injury (IRI). Intravital two-photon microscopy has shown that neutrophils accumulate in large numbers in cardiac and pulmonary grafts within a few hours of reperfusion [23, 24] . Notably, monocytes regulate transendothelial migration of neutrophils into lung grafts and may provide chemotactic cues to them in the graft tissue following extravasation. Zhu has recently provided some insight how neutrophils are recruited into cardiac grafts. High-mobility group box 1 (presumably released from apoptotic cardiomyocytes) stimulated macrophages in a Toll-like receptor 4-dependent manner to produce IL-23. This cytokine stimulated gdT cells to produce IL-17, leading to the production of the neutrophil chemoattractants KC, MIP-2, and LIX. Each component of this pathway was required for efficient recruitment of neutrophils and maximal tissue damage [25] .
Most studies have shown that neutrophilic infiltration has a deleterious effect on graft survival. Heart allografts survive longer when recipients lack expression of chemokine (C-X-C) receptor (CXCR) 2, a receptor for neutrophil chemokines. The decrease in neutrophil recruitment to the graft delayed T-cell infiltration potentially because of decreased expression of pro-inflammatory chemokines and cytokines including TNF-a, IL-6, and IFN-g. Furthermore, neutrophil depletion or inhibition of neutrophil chemotactic pathways synergizes with costimulatory blockade in prolonging the survival of cardiac allografts [26] . One group, after finding that CXCR2-deficient mice reach euglycemia following pancreatic islet transplant more rapidly and consistently compared with wildtype mice, endeavored to treat human islet transplant recipients with the CXCR1/2 inhibitor reparixin. In contrast to untreated controls, patients receiving this drug had improved transplant outcomes with glycemic control and decreased insulin requirement [27 && ]. Using two-photon microscopy, our group observed that neutrophils interact with donor dendritic cells within lung allografts shortly after transplantation. TNF-a production by neutrophils stimulated dendritic cells to produce IL-12, which skewed T-cell differentiation toward T h 1 and triggered graft rejection [28] . Neutrophils recruited to murine pulmonary allografts in response to respiratory infection with P. aeruginosa express B7 and provide costimulation in trans to alloreactive CD4 þ T cells, thereby enhancing alloimmune responses [29] . In a study of lung transplant recipients, increased neutrophilia was associated with the presence of donor-specific antibodies which correlated inversely with allograft survival [30] .
Although neutrophils are generally associated with poor outcomes following transplantation, Christoffersson [31] has characterized an important role of a subset of these cells in the vascularization of transplanted hypoxic tissue. CD11b þ Gr-1 þ CXCR4 hi cells were recruited to transplanted pancreatic islets in response to vascular endothelial growth factor-A. These cells had a phenotype distinct from neutrophils recruited by the inflammatory chemokine MIP-2, expressing far higher levels of MMP-9, a matrix metalloproteinase responsible for degrading the components of the extracellular matrix. This unique neutrophil subset through expression of MMP-9 was required for optimal revascularization of transplanted islets.
NATURAL KILLER CELLS
NK cells, known for their capacity to kill virally infected cells and tumor cells, are able to both downregulate alloimmune responses and promote graft rejection [32] . Tolerance to islet allografts, mediated through treatment with either anti-CD154 or antilymphocyte function associated antigen-1, was found to be dependent on the presence of NK cells [33] . NK cells mediated the tolerogenic effects in these models in perforin-dependent fashion. Yu [34] demonstrated that NK cells promote immunosuppression-mediated, long-term survival of skin allografts through elimination of donor passenger leukocytes. Jungraithmayr [35] recently extended these findings and observed that IL-15-stimulated NK cells eliminate donor dendritic cells through perforin-dependent mechanisms in a lung transplant model. Killing these dendritic cells abrogated the downstream activation of allogeneic T cells and therefore attenuated allograft rejection. In lymphopenic hosts, NK cells attenuate the homeostatic proliferation of memory CD8 þ T cells by competing for IL-15 [36] . Under these circumstances, NK cell depletion can result in accelerated allograft rejection. IL-15, however, was shown in earlier studies to be responsible for activating NK cells, which mediated the rejection of skin allografts. Of note, this observation was made in a RAG -/host, in which T and B cells were not present [37] .
In a model in which allogeneic splenocytes were injected into naive hosts, NK cells killed transplanted cells in a perforin-dependent manner presumably because of 'missing self' recognition [11] . There also exists evidence that different NK cell subsets are important in rejection of bone marrow allografts. Those expressing Ly49 bind self-MHC and if those MHC molecules are not present, NK cells will eliminate them [38] . This provides evidence for the functional education of NK cells, whereby they are 'licensed' during the development to be tolerant to cells with specific MHC I molecules. In the absence of these MHC molecules, cells are considered foreign and therefore are eliminated. Transplanting parental hearts into F1 mice results in the development of chronic allograft vasculopathy, which is dependent on NK cells and recipient IFN-g [39] . Donor-specific antibodies lead to chronic allograft vasculopathy in a NK-cell-dependent manner. This mechanism of rejection is dependent on the Fc portion of antibodies, but is independent of complement [40] .
PLATELETS
Platelets are cells small in size, but large in number that are efficient at binding to the endothelium. Their location along the vasculature allows for platelet interaction with various cell types recruited to the transplanted organs. In a skin transplant model, Swaim et al. [41] recently demonstrated that these cells are able to exacerbate tissue rejection through amplification of T-cell recruitment and release of inflammatory mediators. Depletion of these cells resulted in prolongation of graft survival and was associated with decreased plasma levels of TNF-a and IFN-g. T-cell recruitment was thought to be amplified because of glutamate receptor signaling on platelets stimulating the production of thromboxane.
Interactions between platelets and T cells have been observed in bone marrow transplant models as well, in which transfusion of platelets increases the risk of rejection of allogeneic bone marrow inoculums [42] . Platelet transfusion primed alloimmunity in a CD4 þ -dependent and CD8 þ -dependent manner, although only CD8 þ T cells were responsible for rejection. Minor histocompatibility mismatches on the platelets were necessary for priming the rejection event.
CONCLUSION
This review has highlighted the complex role of innate cells in transplant rejection. Macrophages, neutrophils, and NK cells are all capable of both prolonging allograft survival and hindering it (Table 1) . Often, unique subsets of these cells or the microenvironment in which they are activated are the determining factors in their impact on transplant outcomes. Therefore, attempts at targeting the innate immune cells will need to have specificity for uniquely pro-inflammatory molecules or cell subsets. An exciting alternative in the treatment of transplant recipients might also be in stimulating innate cell subsets capable of promoting allograft tolerance. [18] Kill transplanted cells by phagocytosis [11] Regulate allogeneic T cells through IDO [20] Enhance adaptive immunity [8, 9] Promote wound healing after transplant [22] MHC receptor mediated rejection [12,3,4 & ] Enhance fibrosis [17] Neutrophils CXCR4 hi subset necessary for revascularization [31] Enhance adaptive immunity [25, 26, 28] Presence associated with donor-specific antibodies [30] NK cells Kill DCs to prevent downstream activation of allogeneic T cells [34, 35] Kill transplanted cells with perforin because of missing self [11, 38, 39] Platelets Enhance adaptive immunity through recruitment [41] and priming [42] of T cells DCs, dendritic cells.
